Shell Asset Management CO Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Shell Asset Management CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $70,445 - $74,012	-486 Reduced 20.7%	1,862 $281,000
Q2 2022 Aug 09, 2022	BUY	$83.14 - $145.99 $332 - $583	4 Added 0.17%	2,348 $342,000
Q1 2022 May 04, 2022	SELL	$110.08 - $142.92 $38,087 - $49,450	-346 Reduced 12.86%	2,344 $278,000
Q4 2021 Feb 09, 2022	BUY	$99.73 - $148.48 $1,894 - $2,821	19 Added 0.71%	2,690 $371,000
Q3 2021 Nov 04, 2021	SELL	$98.85 - $138.91 $10,873 - $15,280	-110 Reduced 3.96%	2,671 $371,000
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $9,867 - $15,753	150 Added 5.7%	2,781 $270,000
Q1 2021 May 10, 2021	SELL	$64.07 - $91.75 $127,627 - $182,766	-1,992 Reduced 43.09%	2,631 $180,000
Q2 2020 Aug 10, 2020	SELL	$29.01 - $74.23 $2,407 - $6,161	-83 Reduced 1.76%	4,623 $338,000
Q1 2020 May 11, 2020	SELL	$27.51 - $57.29 $1,953 - $4,067	-71 Reduced 1.49%	4,706 $160,000
Q4 2019 Feb 13, 2020	SELL	$40.86 - $57.65 $5,475 - $7,725	-134 Reduced 2.73%	4,777 $260,000
Q3 2019 Nov 12, 2019	SELL	$37.38 - $49.47 $1,569 - $2,077	-42 Reduced 0.85%	4,911 $205,000
Q2 2019 Aug 12, 2019	SELL	$39.79 - $67.01 $4,456 - $7,505	-112 Reduced 2.21%	4,953 $217,000
Q4 2018 Feb 13, 2019	SELL	$29.75 - $42.9 $11,900 - $17,160	-400 Reduced 7.32%	5,065 $187,000
Q3 2018 Nov 13, 2018	BUY	$32.79 - $43.0 $179,197 - $234,995	5,465 New	5,465 $205,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.